Research indexAnimal study
第一部份:深層海水對餵食高膽固醇小白鼠心臟異常的改善效果第二部份:抗氧化中藥厚朴萃取物在皮膚疾患之應用
沈瑞隆
中山醫學大學醫學研究所學位論文1 Jan 2011
NobleIDark:/48914/w1/20260515/5DB2EC49DOI10.6834/csmu.2011.00116
第一部份:深層海水對餵食高膽固醇小白鼠心臟異常的改善效果第二部份:抗氧化中藥厚朴萃取物在皮膚疾患之應用
沈瑞隆 · 中山醫學大學醫學研究所學位論文 · 2011 · Subscription
NobleIDark:/48914/w1/20260515/5DB2EC49DOI10.6834/csmu.2011.00116
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
Part 1 PRACTICAL APPLICATIONS Deep-sea water (DSW) has been applied on several fields including aquaculture, agriculture, food processing, cosmetics, and medicine. Recently, we have indicated that high-cholesterol dietary mice drinking ED-DSW showed decreased serum lipids, blood pressure and improving blood cholesterol profile. In this study, we further demonstrated the beneficial effects of ED-DSW on high-cholesterol-dietary mice by reducing abnormal cardiac architecture, apoptosis in left ventricle and increasing cardiac survival signaling, such as insulin-like growth factor-1 receptor (IGF-1R), phosphoinositide-3-kinases (PI3K) and p-AKT/AKT ratio. Altogether, these findings indicated that ED-DSW revealed the cardiac protective effects and might be suggested as an ingredient of cardiovascular health food in a variety of niche markets. Part 2 Chinese herbs have been and still are widely used as important remedies in Oriental medicine. Over the recent years, a variety of biologically active constituents have been isolated from these sources and confirmed to have multifunctional activity in experimental studies. Honokiol is a small-molecule polyphenol isolated from the genus Magnolia. It is accompanied by other related polyphenols, including magnolol, with which it shares certain biological properties. Recently, honokiol and magnolol have been found to have anti-oxidative, anti-inflammatory, anti-tumor, and anti-microbial properties in preclinical models, without appreciable toxicity. These findings have increased interest in bringing honokiol and magnolol to the clinic as novel therapeutic agents in dermatology. In this review, the findings concerning the major mechanisms of action of honokiol and magnolol are described. Knowledge of the multiple activities of honokiol and magnolol can assist with the development of honokiol and magnolol derivatives and the design of clinical trials that will maximize the potential benefit of honokiol and magnolol in the patient setting for dermatologic disorders.